ARC Award for Studying the Connectivity Between Epigenetic Factors and Metabolism to Support Biomarker or Therapeutic Development in Neurodegenerative Diseases Grant

ARC Award for Studying the Connectivity Between Epigenetic Factors and Metabolism to Support Biomarker or Therapeutic Development in Neurodegenerative Diseases Grant

Status: ACTIVE
Funder: Agilent Technologies Foundation
Amount: Up to US $500,000
Last Updated: October 15, 2025

Summary

The ARC Award focuses on the connectivity between epigenetic factors and metabolism to support the development of biomarkers or therapies for neurodegenerative diseases. Agilent Technologies Foundation aims to foster innovation through collaborations with academic and non-profit research institutions, providing funding of up to $500K over three years. Proposals should incorporate advanced methodologies including DNA and methylation analysis, without compromising sample integrity, to enhance understanding of disease progression.

Overview

Fostering scientific innovation through strategic academic programs and partnerships At Agilent, the University Relations and External Research department has a long-standing tradition of collaborating with academic institutions and non-profit research organizations. We empower researchers to address complex scientific challenges in fields such as life sciences, pharmaceuticals and biopharmaceuticals, clinical diagnostics, advanced materials, and food and environmental research. Our mission is to create synergies between Agilent and research institutions that accelerate progress in academic and research initiatives. We prioritize transparency, accountability, and best practices in every partnership, providing access to cutting-edge technologies, expert insights, and financial support. By supporting groundbreaking research, we are committed to fueling innovation and enabling researchers to shape the future of scientific discovery. Studying the Connectivity Between Epigenetic Factors and Metabolism to Support Biomarker or Therapeutic Development in Neurodegenerative Diseases Additional Information: Proposals incorporating the development and evaluation of DNA and methylation marker candidates—without sample splitting or signal loss in cfDNA—and associating these markers with metabolic factors influencing the progression of neurodegenerative disease are encouraged. Proposals that leverage multimodal data including cell analysis tools and mass spectrometry synergistically with DNA and methylation and marker candidates are encouraged Applications with coinvestigators at the same institution are permitted to encourage multimodal approaches. Award Details Research projects should be scoped for a 3-year period with a total requested budget up to $500K (USD). Cash award is provided to the institution in the name of the awardee, in equal annual installments over the funding period. Awards have no deliverables and must be free of overhead or other fees. Principal investigator awardee will be invited to visit and present research seminar at Agilent site (expenses covered).

Eligibility

You can learn more about this opportunity by visiting the funder's website. Institution and Applicant eligibility Institution must be a degree-granting academic or a non-profit research institution.Applicant must hold a tenure-tracked faculty position and be authorized to serve as a principal investigator for research contracts and principal advisor of doctoral candidates at the institution.